Fundz

Syndax Pharmaceuticals Inc reported raising $61.3 Million in an initial SEC Form D filing, from an offering of $61.3 Million

PUBLIC · SNDXAug 28, 2015

Amount Raised

$61.3 Million

$61.3 Million sold, per SEC Form D (first sale Aug 28, 2015)

Round Type

Venture

New YorkBiotechnologyHealthcarePharmaceuticalBiopharma

Quick answer

Syndax Pharmaceuticals raised $61.3 Million in a funding round, dated August 28, 2015. Syndax Pharmaceuticals is based in New York, New York, United States.

How much did Syndax Pharmaceuticals raise?
Syndax Pharmaceuticals raised $61.3 Million in a funding round on August 28, 2015.
What does Syndax Pharmaceuticals do?
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies.
Where is Syndax Pharmaceuticals based and how big is it?
Syndax Pharmaceuticals is based in New York, New York, United States. Fundz records about 184 employees.
Who are the decision-makers at Syndax Pharmaceuticals?
Fundz holds 1 contact at Syndax Pharmaceuticals. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Pharmaceutical around the same time

Companies in the same sectors as Syndax Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Corvus Pharmaceuticals, Inc. raised $75M on September 25, 2015.
  • SpineThera, Inc. raised $400K (Seed) on September 9, 2015.
  • VistaGen raised $1.9M on August 6, 2015.
  • SpineThera, Inc. raised $2.4M (Seed) on August 5, 2015.
  • OCUCURE THERAPEUTICS INC raised $200K (Pre-Seed) on October 6, 2015.
  • CytoDyn raised $2.7M (Seed) on October 5, 2015.

Who to call at Syndax Pharmaceuticals, and when

A new round usually means Syndax Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Syndax Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Syndax Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Syndax Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Syndax Pharmaceuticals

Location

New York, New York, United States

About

Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company's pipeline include Revuforj® (revumenib), an FDA-approved menin inhibitor, and Niktimvo™ (axatilimab-csfr), an FDA-approved monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Syndax Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Syndax Pharmaceuticals's next move

See what Strategic adds

Syndax Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.